Beijing Beilu Pharmaceutical Free Cash Flow Generation Index
Beijing Beilu Pharmaceutical free cash flow generation index. Beijing Beilu Pharmaceutical (300016) has a Free Cash Flow Generation Index of 0.22x as of September 2025. Free cash flow of CN¥16.70 Million represents 0% of operating cash flow (CN¥74.66 Million). Check Beijing Beilu Pharmaceutical (300016) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Beijing Beilu Pharmaceutical (2006–2024)
Free cash flow generation index of Beijing Beilu Pharmaceutical from 2006 to 2024. Historical FCF Generation Index trend for Beijing Beilu Pharmaceutical across 18 annual periods. Explore 300016 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Beijing Beilu Pharmaceutical Free Cash Flow Generation Index by Year (2006–2024)
Beijing Beilu Pharmaceutical free cash flow generation index by year from 2006 to 2024. Year-by-year Free Cash Flow Generation Index for Beijing Beilu Pharmaceutical. For the full cash flow conversion analysis, see how efficiently does Beijing Beilu Pharmaceutical generate cash.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.38x | CN¥61.63 Million | CN¥163.02 Million | CN¥101.39 Million | ▲ +125.7% |
| 2023 | -1.47x | CN¥-86.15 Million | CN¥58.46 Million | CN¥144.61 Million | ▼ -852.5% |
| 2022 | 0.20x | CN¥25.03 Million | CN¥127.81 Million | CN¥102.78 Million | ▲ +154.6% |
| 2021 | -0.36x | CN¥-39.03 Million | CN¥108.73 Million | CN¥147.76 Million | ▼ -1719.0% |
| 2020 | 0.02x | CN¥3.90 Million | CN¥176.00 Million | CN¥172.10 Million | ▼ -97.1% |
| 2019 | 0.78x | CN¥121.82 Million | CN¥156.81 Million | CN¥34.99 Million | ▲ +12.2% |
| 2018 | 0.69x | CN¥121.70 Million | CN¥175.75 Million | CN¥54.06 Million | ▲ +11.6% |
| 2017 | 0.62x | CN¥89.93 Million | CN¥144.92 Million | CN¥55.00 Million | ▲ +47.9% |
| 2016 | 0.42x | CN¥31.96 Million | CN¥76.17 Million | CN¥44.21 Million | ▲ +192.0% |
| 2015 | 0.14x | CN¥11.62 Million | CN¥80.85 Million | CN¥69.23 Million | ▲ +789.1% |
| 2014 | -0.02x | CN¥-878.11K | CN¥42.11 Million | CN¥42.99 Million | ▼ -114.6% |
| 2013 | 0.14x | CN¥5.89 Million | CN¥41.37 Million | CN¥35.48 Million | ▲ +108.0% |
| 2012 | -1.78x | CN¥-40.61 Million | CN¥22.86 Million | CN¥63.47 Million | ▼ -686.5% |
| 2011 | 0.30x | CN¥13.85 Million | CN¥45.73 Million | CN¥31.87 Million | ▲ +179.7% |
| 2010 | -0.38x | CN¥-14.26 Million | CN¥37.51 Million | CN¥51.77 Million | ▼ -141.8% |
| 2009 | 0.91x | CN¥52.60 Million | CN¥57.91 Million | CN¥5.32 Million | ▼ -7.5% |
| 2007 | 0.98x | CN¥12.05 Million | CN¥12.28 Million | CN¥228.50K | ▲ +6.3% |
| 2006 | 0.92x | CN¥18.14 Million | CN¥19.65 Million | CN¥1.51 Million | — |